Bracco Imaging's BR55, a novel ultrasound molecular imaging agent targeting VEGFR2, receives FDA Fast Track designation for detecting active bowel inflammation in Crohn's disease patients.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.